Loading clinical trials...
Loading clinical trials...
Feasibility of Using the ARESTM Device to Measure Sleep Parameters in Men With Asymptomatic Prostate Cancer Before as Well as at 3 and 6 Months After Starting Androgen Deprivation Therapy
Conditions
Interventions
ARESTM
Locations
1
Canada
Vancouver Prostate Centre
Vancouver, British Columbia, Canada
Start Date
July 1, 2015
Primary Completion Date
September 1, 2018
Completion Date
September 1, 2018
Last Updated
October 3, 2019
NCT06430957
NCT01778504
NCT07476053
NCT07477236
NCT07225946
NCT07292922
Lead Sponsor
Vancouver Prostate Centre
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions